Denali Therapeutics Stock Volatility
| DNLI Stock | USD 25.16 0.48 1.94% |
Denali Therapeutics is very steady at the moment. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0177, which denotes the company had a 0.0177% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Mean Deviation of 2.26, downside deviation of 3.64, and Coefficient Of Variation of 4974.7 to check if the risk estimate we provide is consistent with the expected return of 0.0608%. Key indicators related to Denali Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Denali Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Denali daily returns, and it is calculated using variance and standard deviation. We also use Denali's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Denali Therapeutics volatility.
Denali |
ESG Sustainability
While most ESG disclosures are voluntary, Denali Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Denali Therapeutics' managers and investors.Environmental | Governance | Social |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Denali Therapeutics at lower prices. For example, an investor can purchase Denali stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.
Moving against Denali Stock
Denali Therapeutics Market Sensitivity And Downside Risk
Denali Therapeutics' beta coefficient measures the volatility of Denali stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Denali stock's returns against your selected market. In other words, Denali Therapeutics's beta of 2.32 provides an investor with an approximation of how much risk Denali Therapeutics stock can potentially add to one of your existing portfolios. Denali Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Denali Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Denali Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Denali Therapeutics Demand TrendCheck current 90 days Denali Therapeutics correlation with market (Dow Jones Industrial)Denali Beta |
Denali standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.43 |
It is essential to understand the difference between upside risk (as represented by Denali Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Denali Therapeutics' daily returns or price. Since the actual investment returns on holding a position in denali stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Denali Therapeutics.
Denali Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Denali Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Denali Therapeutics' price changes. Investors will then calculate the volatility of Denali Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Denali Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Denali Therapeutics' fluctuations based on previous trends. It's commonly used to predict Denali Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Denali Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Denali Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Denali Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Denali Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 2.3197 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Denali Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Denali Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Denali Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Denali stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Denali Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Denali Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Denali Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Denali Therapeutics is 5650.7. The daily returns are distributed with a variance of 11.8 and standard deviation of 3.43. The mean deviation of Denali Therapeutics is currently at 2.28. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 2.32 | |
σ | Overall volatility | 3.43 | |
Ir | Information ratio | -0.02 |
Denali Therapeutics Stock Return Volatility
Denali Therapeutics historical daily return volatility represents how much of Denali Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.4347% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7496% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Denali Therapeutics Volatility
Volatility is a rate at which the price of Denali Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Denali Therapeutics may increase or decrease. In other words, similar to Denali's beta indicator, it measures the risk of Denali Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Denali Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 15.1 M | 13.4 M | |
| Market Cap | 2.9 B | 2.2 B |
Denali Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Denali Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Denali Therapeutics' price varies over time.
3 ways to utilize Denali Therapeutics' volatility to invest better
Higher Denali Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Denali Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Denali Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Denali Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Denali Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Denali Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Denali Therapeutics Investment Opportunity
Denali Therapeutics has a volatility of 3.43 and is 4.57 times more volatile than Dow Jones Industrial. 30 percent of all equities and portfolios are less risky than Denali Therapeutics. You can use Denali Therapeutics to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Denali Therapeutics to be traded at $27.68 in 90 days.Very weak diversification
The correlation between Denali Therapeutics and DJI is 0.53 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Denali Therapeutics Additional Risk Indicators
The analysis of Denali Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Denali Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Denali Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0231 | |||
| Market Risk Adjusted Performance | 0.035 | |||
| Mean Deviation | 2.26 | |||
| Semi Deviation | 3.51 | |||
| Downside Deviation | 3.64 | |||
| Coefficient Of Variation | 4974.7 | |||
| Standard Deviation | 3.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Denali Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Denali Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Denali Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Denali Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Denali Therapeutics.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |